Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Blood Specimen Collection × 30 days × Clear all

Sponsor

Conditions

Neoplasms 10 Breast Neoplasms 8 Prostatic Neoplasms 3 Uterine Cervical Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Melanoma 2 Lung Diseases 2 Kidney Neoplasms 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Vitamin D Deficiency 1 Vascular Diseases 1 Uveal Melanoma 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Diseases 1 Skin Neoplasms 1 Recurrence 1 Radiation Injuries 1 Pyruvate Kinase Deficiency of Red Cells 1 Pyloric Stenosis, Hypertrophic 1 Postoperative Complications 1 PDAC - Pancreatic Ductal Adenocarcinoma 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1

Interventions

Rituximab 8 Lenalidomide 5 Cyclophosphamide 5 ibrutinib 3 Vincristine 3 Prednisone 3 CT-P10 3 venetoclax 2 orelabrutinib 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Doxorubicin 2 zanubrutinib 1 tafasitamab 1 prednylidene 1 polatuzumab vedotin 1 obinutuzumab 1 ianalumab 1 fludarabine phosphate 1 fludarabine 1 deltacortene 1 cc-486 1 acalabrutinib 1 Whole-Body Irradiation 1 Transplantation 1 Tacrolimus 1 Radiotherapy 1 R-CHOP protocol 1 Pharmacogenomic Testing 1 Peripheral Blood Stem Cell Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡